ReP USP - Resultado da busca

Artigo de periodico
"Blood-brain barrier lesion - a novel determinant of autonomic imbalance in heart failure and the effects of exercise training " (2023)
Raquel, Hiviny de Ataides ; Perego, Sany M. ; Masson, Gustavo S.; Jensen, Leonardo ; Colquhoun, Alison ; Michelini, Lisete Compagno
Fonte: Clinical Science. Unidade: ICB
Assuntos: BIOLOGIA CELULAR, FISIOLOGIA, INSUFICIÊNCIA CARDÍACA ANIMAL, BARREIRA HEMATO-ENCEFÁLICA, RATOS WISTAR, SISTEMA NERVOSO AUTÔNOMO, CIRCULAÇÃO ANIMAL, EXERCÍCIO FÍSICO, PROTEÍNAS DA MEMBRANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAQUEL, Hiviny de Ataides et al. "Blood-brain barrier lesion - a novel determinant of autonomic imbalance in heart failure and the effects of exercise training ". Clinical Science, v. 137, n. 15, p. 1049-1066, 2023Tradução . . Disponível em: https://doi.org/10.1042/CS20230489. Acesso em: 19 out. 2025.
APA
Raquel, H. de A., Perego, S. M., Masson, G. S., Jensen, L., Colquhoun, A., & Michelini, L. C. (2023). "Blood-brain barrier lesion - a novel determinant of autonomic imbalance in heart failure and the effects of exercise training ". Clinical Science, 137( 15), 1049-1066. doi:10.1042/CS20230489
NLM
Raquel H de A, Perego SM, Masson GS, Jensen L, Colquhoun A, Michelini LC. "Blood-brain barrier lesion - a novel determinant of autonomic imbalance in heart failure and the effects of exercise training " [Internet]. Clinical Science. 2023 ; 137( 15): 1049-1066.[citado 2025 out. 19 ] Available from: https://doi.org/10.1042/CS20230489
Vancouver
Raquel H de A, Perego SM, Masson GS, Jensen L, Colquhoun A, Michelini LC. "Blood-brain barrier lesion - a novel determinant of autonomic imbalance in heart failure and the effects of exercise training " [Internet]. Clinical Science. 2023 ; 137( 15): 1049-1066.[citado 2025 out. 19 ] Available from: https://doi.org/10.1042/CS20230489
Artigo de periodico
Diruthenium(II-III)-ibuprofen-loaded chitosan-based microparticles and nanoparticles systems: encapsulation, characterisation, anticancer activity of the nanoformulations against U87MG human glioma cells (2023)
Rehman, Hanif Ur; Fornaciari, Bárbara ; Alves, Samara Rodrigues ; Colquhoun, Alison ; Silva, Denise de Oliveira
Fonte: Journal of Microencapsulation. Unidades: ICB, IQ
Assuntos: NANOPARTÍCULAS, GLIOMA, ANTINEOPLÁSICOS, QUITOSANA, BIOPOLÍMEROS, FLUORESCÊNCIA, MICROSCOPIA DE FORÇA ATÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REHMAN, Hanif Ur et al. Diruthenium(II-III)-ibuprofen-loaded chitosan-based microparticles and nanoparticles systems: encapsulation, characterisation, anticancer activity of the nanoformulations against U87MG human glioma cells. Journal of Microencapsulation, v. 40, n. 7, p. 549-565, 2023Tradução . . Disponível em: https://doi.org/10.1080/02652048.2023.2258967. Acesso em: 19 out. 2025.
APA
Rehman, H. U., Fornaciari, B., Alves, S. R., Colquhoun, A., & Silva, D. de O. (2023). Diruthenium(II-III)-ibuprofen-loaded chitosan-based microparticles and nanoparticles systems: encapsulation, characterisation, anticancer activity of the nanoformulations against U87MG human glioma cells. Journal of Microencapsulation, 40( 7), 549-565. doi:10.1080/02652048.2023.2258967
NLM
Rehman HU, Fornaciari B, Alves SR, Colquhoun A, Silva D de O. Diruthenium(II-III)-ibuprofen-loaded chitosan-based microparticles and nanoparticles systems: encapsulation, characterisation, anticancer activity of the nanoformulations against U87MG human glioma cells [Internet]. Journal of Microencapsulation. 2023 ; 40( 7): 549-565.[citado 2025 out. 19 ] Available from: https://doi.org/10.1080/02652048.2023.2258967
Vancouver
Rehman HU, Fornaciari B, Alves SR, Colquhoun A, Silva D de O. Diruthenium(II-III)-ibuprofen-loaded chitosan-based microparticles and nanoparticles systems: encapsulation, characterisation, anticancer activity of the nanoformulations against U87MG human glioma cells [Internet]. Journal of Microencapsulation. 2023 ; 40( 7): 549-565.[citado 2025 out. 19 ] Available from: https://doi.org/10.1080/02652048.2023.2258967
Artigo de periodico
Trained hypertensive rats exhibit decreased transcellular vesicle trafficking, increased tight junctions’ density, restored blood-brain barrier permeability and normalized autonomic control of the circulation (2023)
Candido, Vanessa B. ; Perego, Sany M. ; Metzger, Martin Andreas ; Colquhoun, Alison ; Michelini, Lisete Compagno
Fonte: Frontiers in Physiology. Unidade: ICB
Assuntos: FISIOLOGIA, BIOLOGIA CELULAR, EXERCÍCIO FÍSICO, TREINAMENTO AERÓBIO, BARREIRA HEMATO-ENCEFÁLICA, HIPERTENSÃO, MODELOS ANIMAIS DE DOENÇAS, RATOS, CIRCULAÇÃO ANIMAL, MICROSCOPIA ELETRÔNICA, PRESSÃO SANGUÍNEA, HIPOTÁLAMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANDIDO, Vanessa B. et al. Trained hypertensive rats exhibit decreased transcellular vesicle trafficking, increased tight junctions’ density, restored blood-brain barrier permeability and normalized autonomic control of the circulation. Frontiers in Physiology, v. 14, p. 1-14, 2023Tradução . . Disponível em: https://doi.org/10.3389/fphys.2023.1069485. Acesso em: 19 out. 2025.
APA
Candido, V. B., Perego, S. M., Metzger, M. A., Colquhoun, A., & Michelini, L. C. (2023). Trained hypertensive rats exhibit decreased transcellular vesicle trafficking, increased tight junctions’ density, restored blood-brain barrier permeability and normalized autonomic control of the circulation. Frontiers in Physiology, 14, 1-14. doi:10.3389/fphys.2023.1069485
NLM
Candido VB, Perego SM, Metzger MA, Colquhoun A, Michelini LC. Trained hypertensive rats exhibit decreased transcellular vesicle trafficking, increased tight junctions’ density, restored blood-brain barrier permeability and normalized autonomic control of the circulation [Internet]. Frontiers in Physiology. 2023 ; 14 1-14.[citado 2025 out. 19 ] Available from: https://doi.org/10.3389/fphys.2023.1069485
Vancouver
Candido VB, Perego SM, Metzger MA, Colquhoun A, Michelini LC. Trained hypertensive rats exhibit decreased transcellular vesicle trafficking, increased tight junctions’ density, restored blood-brain barrier permeability and normalized autonomic control of the circulation [Internet]. Frontiers in Physiology. 2023 ; 14 1-14.[citado 2025 out. 19 ] Available from: https://doi.org/10.3389/fphys.2023.1069485
Artigo de periodico
Effect of polyunsaturated fatty acids on temozolomide drug-sensitive and drug-resistant glioblastoma cells (2023)
Silva, Janaína Alessandra ; Colquhoun, Alison
Fonte: Biomedicines. Unidade: ICB
Assuntos: BIOLOGIA CELULAR, ÁCIDOS GRAXOS, CÉLULAS CULTIVADAS DE TUMOR, GLIOMA, NEOPLASIAS CEREBRAIS, ANTINEOPLÁSICOS, CITOMETRIA DE FLUXO, WESTERN BLOTTING, CITOPLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Janaína Alessandra e COLQUHOUN, Alison. Effect of polyunsaturated fatty acids on temozolomide drug-sensitive and drug-resistant glioblastoma cells. Biomedicines, v. 11, n. 3, p. 1-21, 2023Tradução . . Disponível em: https://doi.org/10.3390/biomedicines11030779. Acesso em: 19 out. 2025.
APA
Silva, J. A., & Colquhoun, A. (2023). Effect of polyunsaturated fatty acids on temozolomide drug-sensitive and drug-resistant glioblastoma cells. Biomedicines, 11( 3), 1-21. doi:10.3390/biomedicines11030779
NLM
Silva JA, Colquhoun A. Effect of polyunsaturated fatty acids on temozolomide drug-sensitive and drug-resistant glioblastoma cells [Internet]. Biomedicines. 2023 ; 11( 3): 1-21.[citado 2025 out. 19 ] Available from: https://doi.org/10.3390/biomedicines11030779
Vancouver
Silva JA, Colquhoun A. Effect of polyunsaturated fatty acids on temozolomide drug-sensitive and drug-resistant glioblastoma cells [Internet]. Biomedicines. 2023 ; 11( 3): 1-21.[citado 2025 out. 19 ] Available from: https://doi.org/10.3390/biomedicines11030779
Artigo de periodico
Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells (2021)
Jiménez, Juan de los Santos; Sandoval, José A. Campos ; Torres, Clara Márquez; Polo, Nieves Urbano; Brøndegaard, David; Rufián, Mercedes Martín; Lobo, Carolina; Alonso, Ana Peñalver ; García, María C. Gómez; Campos, Janet Martín ; Cardona, Carolina; Castilla, Laura; Souza, Felipe da Costa ; Cheng, Tzuling ; Segura, Juan A.; Alonso, Francisco J.; Curi, Rui ; Colquhoun, Alison ; DeBerardinis, Ralph J. ; Márquez, Javier; Matés, José M.
Fonte: Journal of Biomedical Science. Unidade: ICB
Assuntos: BIOLOGIA CELULAR, GLUTAMINA, GLIOMA, NEOPLASIAS CEREBRAIS, ESTRESSE OXIDATIVO, MICRORNAS, ANTIOXIDANTES, ONCOPROTEÍNAS, ESPECTROFOTOMETRIA, ENZIMAS OXIRREDUTORAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JIMÉNEZ, Juan de los Santos et al. Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells. Journal of Biomedical Science, v. 28, p. 16 , 2021Tradução . . Disponível em: https://doi.org/10.1186/s12929-021-00712-y. Acesso em: 19 out. 2025.
APA
Jiménez, J. de los S., Sandoval, J. A. C., Torres, C. M., Polo, N. U., Brøndegaard, D., Rufián, M. M., et al. (2021). Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells. Journal of Biomedical Science, 28, 16 . doi:10.1186/s12929-021-00712-y
NLM
Jiménez J de los S, Sandoval JAC, Torres CM, Polo NU, Brøndegaard D, Rufián MM, Lobo C, Alonso AP, García MCG, Campos JM, Cardona C, Castilla L, Souza F da C, Cheng T, Segura JA, Alonso FJ, Curi R, Colquhoun A, DeBerardinis RJ, Márquez J, Matés JM. Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells [Internet]. Journal of Biomedical Science. 2021 ; 28 16 .[citado 2025 out. 19 ] Available from: https://doi.org/10.1186/s12929-021-00712-y
Vancouver
Jiménez J de los S, Sandoval JAC, Torres CM, Polo NU, Brøndegaard D, Rufián MM, Lobo C, Alonso AP, García MCG, Campos JM, Cardona C, Castilla L, Souza F da C, Cheng T, Segura JA, Alonso FJ, Curi R, Colquhoun A, DeBerardinis RJ, Márquez J, Matés JM. Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells [Internet]. Journal of Biomedical Science. 2021 ; 28 16 .[citado 2025 out. 19 ] Available from: https://doi.org/10.1186/s12929-021-00712-y
Artigo de periodico
A novel μ-oxo-diruthenium(III,III)-ibuprofen-(4-aminopyridine) chloride derived from the diruthenium(II,III)-ibuprofen paddlewheel metallodrug shows anticancer properties (2021)
Alves, Samara Rodrigues ; Santos, Rodrigo Luis da Silva Ribeiro dos ; Fornaciari, Bárbara ; Colquhoun, Alison ; Silva, Denise de Oliveira
Fonte: Journal of Inorganic Biochemistry. Unidades: ICB, IQ
Assuntos: BIOLOGIA CELULAR, NEOPLASIAS, MEDICAMENTO, INFLAMAÇÃO, ANTI-INFLAMATÓRIOS ESTEROIDES, GLIOMA, NEOPLASIAS CEREBRAIS, CÉLULAS CULTIVADAS DE TUMOR, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Samara Rodrigues et al. A novel μ-oxo-diruthenium(III,III)-ibuprofen-(4-aminopyridine) chloride derived from the diruthenium(II,III)-ibuprofen paddlewheel metallodrug shows anticancer properties. Journal of Inorganic Biochemistry, v. 225, p. 1-10, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jinorgbio.2021.111596. Acesso em: 19 out. 2025.
APA
Alves, S. R., Santos, R. L. da S. R. dos, Fornaciari, B., Colquhoun, A., & Silva, D. de O. (2021). A novel μ-oxo-diruthenium(III,III)-ibuprofen-(4-aminopyridine) chloride derived from the diruthenium(II,III)-ibuprofen paddlewheel metallodrug shows anticancer properties. Journal of Inorganic Biochemistry, 225, 1-10. doi:10.1016/j.jinorgbio.2021.111596
NLM
Alves SR, Santos RL da SR dos, Fornaciari B, Colquhoun A, Silva D de O. A novel μ-oxo-diruthenium(III,III)-ibuprofen-(4-aminopyridine) chloride derived from the diruthenium(II,III)-ibuprofen paddlewheel metallodrug shows anticancer properties [Internet]. Journal of Inorganic Biochemistry. 2021 ; 225 1-10.[citado 2025 out. 19 ] Available from: https://doi.org/10.1016/j.jinorgbio.2021.111596
Vancouver
Alves SR, Santos RL da SR dos, Fornaciari B, Colquhoun A, Silva D de O. A novel μ-oxo-diruthenium(III,III)-ibuprofen-(4-aminopyridine) chloride derived from the diruthenium(II,III)-ibuprofen paddlewheel metallodrug shows anticancer properties [Internet]. Journal of Inorganic Biochemistry. 2021 ; 225 1-10.[citado 2025 out. 19 ] Available from: https://doi.org/10.1016/j.jinorgbio.2021.111596
Artigo de periodico
Cyclooxygenase inhibition alters proliferative, migratory, and invasive properties of human glioblastoma cells in vitro (2021)
Ferreira, Matthew Thomas ; Miyake, Juliano Andreoli ; Gomes, Renata Nascimento ; Feitoza, Fábio; Stevannato, Pollyana Bulgarelli; Cunha, Andrew Silva da; Serachi, Fernanda de Oliveira; Panagopoulos, Alexandros Theodoros; Colquhoun, Alison
Fonte: International Journal of Molecular Sciences. Unidades: ICB, FM
Assuntos: BIOLOGIA CELULAR, GLIOMA, NEOPLASIAS CEREBRAIS, METALOPROTEINASES, PROSTAGLANDINAS, ASTROCITOMA, CITOMETRIA DE FLUXO, EXPRESSÃO GÊNICA, WESTERN BLOTTING
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Matthew Thomas et al. Cyclooxygenase inhibition alters proliferative, migratory, and invasive properties of human glioblastoma cells in vitro. International Journal of Molecular Sciences, v. 22, n. 9, p. 1-23, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms22094297. Acesso em: 19 out. 2025.
APA
Ferreira, M. T., Miyake, J. A., Gomes, R. N., Feitoza, F., Stevannato, P. B., Cunha, A. S. da, et al. (2021). Cyclooxygenase inhibition alters proliferative, migratory, and invasive properties of human glioblastoma cells in vitro. International Journal of Molecular Sciences, 22( 9), 1-23. doi:10.3390/ijms22094297
NLM
Ferreira MT, Miyake JA, Gomes RN, Feitoza F, Stevannato PB, Cunha AS da, Serachi F de O, Panagopoulos AT, Colquhoun A. Cyclooxygenase inhibition alters proliferative, migratory, and invasive properties of human glioblastoma cells in vitro [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 9): 1-23.[citado 2025 out. 19 ] Available from: https://doi.org/10.3390/ijms22094297
Vancouver
Ferreira MT, Miyake JA, Gomes RN, Feitoza F, Stevannato PB, Cunha AS da, Serachi F de O, Panagopoulos AT, Colquhoun A. Cyclooxygenase inhibition alters proliferative, migratory, and invasive properties of human glioblastoma cells in vitro [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 9): 1-23.[citado 2025 out. 19 ] Available from: https://doi.org/10.3390/ijms22094297
Trabalho de evento-resumo periodico
Ultrastructural changes in blood-brain barrier (BBB): effects of hypertension and aerobic training (2020)
Abreu, Vanessa Candido ; Ceroni, Alexandre; Colquhoun, Alison ; Michelini, Lisete Compagno
Fonte: Journal of Clinical Hypertension. Nome do evento: Annual Meeting of the Brazilian Society of Hypertension. Unidade: ICB
Assuntos: FISIOLOGIA, BIOLOGIA CELULAR, BARREIRA HEMATO-ENCEFÁLICA, HIPERTENSÃO, TREINAMENTO AERÓBIO, MICROSCOPIA ELETRÔNICA ANIMAL, PRESSÃO SANGUÍNEA, RATOS WISTAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABREU, Vanessa Candido et al. Ultrastructural changes in blood-brain barrier (BBB): effects of hypertension and aerobic training. Journal of Clinical Hypertension. Hoboken: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/jch.13745. Acesso em: 19 out. 2025. , 2020
APA
Abreu, V. C., Ceroni, A., Colquhoun, A., & Michelini, L. C. (2020). Ultrastructural changes in blood-brain barrier (BBB): effects of hypertension and aerobic training. Journal of Clinical Hypertension. Hoboken: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1111/jch.13745
NLM
Abreu VC, Ceroni A, Colquhoun A, Michelini LC. Ultrastructural changes in blood-brain barrier (BBB): effects of hypertension and aerobic training [Internet]. Journal of Clinical Hypertension. 2020 ; 22( 4): 694.[citado 2025 out. 19 ] Available from: https://doi.org/10.1111/jch.13745
Vancouver
Abreu VC, Ceroni A, Colquhoun A, Michelini LC. Ultrastructural changes in blood-brain barrier (BBB): effects of hypertension and aerobic training [Internet]. Journal of Clinical Hypertension. 2020 ; 22( 4): 694.[citado 2025 out. 19 ] Available from: https://doi.org/10.1111/jch.13745
Artigo de periodico
Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells (2020)
Alves, Samara Rodrigues; Colquhoun, Alison ; Wu, Xiao Yu; Silva, Denise de Oliveira
Fonte: Journal of Inorganic Biochemistry. Unidades: ICB, IQ
Assuntos: BIOLOGIA CELULAR, CÉLULAS CULTIVADAS DE TUMOR, ESPECTROMETRIA DE MASSAS, NANOPARTÍCULAS, GLIOMA, NEOPLASIAS CEREBRAIS, ANTI-INFLAMATÓRIOS NÃO ESTEROIDES, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Samara Rodrigues et al. Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells. Journal of Inorganic Biochemistry, v. 205, p. 9 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jinorgbio.2019.110984. Acesso em: 19 out. 2025.
APA
Alves, S. R., Colquhoun, A., Wu, X. Y., & Silva, D. de O. (2020). Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells. Journal of Inorganic Biochemistry, 205, 9 . doi:10.1016/j.jinorgbio.2019.110984
NLM
Alves SR, Colquhoun A, Wu XY, Silva D de O. Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells [Internet]. Journal of Inorganic Biochemistry. 2020 ; 205 9 .[citado 2025 out. 19 ] Available from: https://doi.org/10.1016/j.jinorgbio.2019.110984
Vancouver
Alves SR, Colquhoun A, Wu XY, Silva D de O. Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells [Internet]. Journal of Inorganic Biochemistry. 2020 ; 205 9 .[citado 2025 out. 19 ] Available from: https://doi.org/10.1016/j.jinorgbio.2019.110984
Artigo de periodico
Plasma lipid profile and systemic inflammation in patients with cancer cachexia (2020)
Riccardi, Daniela Mendes dos Reis ; Neves, Rodrigo Xavier; Matos-Neto, Emidio Marques de ; Camargo, Rodolfo Gonzalez; Lima, Joanna Darck Carola Correia ; Radloff, Katrin; Alves, Michele Joana ; Costa, Raquel Galvão Figuerêdo ; Tokeshi, Flavio ; Otoch, José Pinhata ; Maximiano, Linda Ferreira ; Alcântara, Paulo Sérgio Martins de ; Colquhoun, Alison ; Laviano, Alessandro ; Seelaender, Marília Cerqueira Leite
Fonte: Frontiers in Nutrition. Unidades: HU, ICB, FM
Assuntos: BIOLOGIA CELULAR, NEOPLASIAS, CAQUEXIA, INFLAMAÇÃO, ÁCIDOS GRAXOS, LIPÍDEOS, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RICCARDI, Daniela Mendes dos Reis et al. Plasma lipid profile and systemic inflammation in patients with cancer cachexia. Frontiers in Nutrition, v. 7, n. ja 2020, p. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fnut.2020.00004. Acesso em: 19 out. 2025.
APA
Riccardi, D. M. dos R., Neves, R. X., Matos-Neto, E. M. de, Camargo, R. G., Lima, J. D. C. C., Radloff, K., et al. (2020). Plasma lipid profile and systemic inflammation in patients with cancer cachexia. Frontiers in Nutrition, 7( ja 2020), 11. doi:10.3389/fnut.2020.00004
NLM
Riccardi DM dos R, Neves RX, Matos-Neto EM de, Camargo RG, Lima JDCC, Radloff K, Alves MJ, Costa RGF, Tokeshi F, Otoch JP, Maximiano LF, Alcântara PSM de, Colquhoun A, Laviano A, Seelaender MCL. Plasma lipid profile and systemic inflammation in patients with cancer cachexia [Internet]. Frontiers in Nutrition. 2020 ; 7( ja 2020): 11.[citado 2025 out. 19 ] Available from: https://doi.org/10.3389/fnut.2020.00004
Vancouver
Riccardi DM dos R, Neves RX, Matos-Neto EM de, Camargo RG, Lima JDCC, Radloff K, Alves MJ, Costa RGF, Tokeshi F, Otoch JP, Maximiano LF, Alcântara PSM de, Colquhoun A, Laviano A, Seelaender MCL. Plasma lipid profile and systemic inflammation in patients with cancer cachexia [Internet]. Frontiers in Nutrition. 2020 ; 7( ja 2020): 11.[citado 2025 out. 19 ] Available from: https://doi.org/10.3389/fnut.2020.00004
Artigo de periodico
Gamma-Linolenic acid alters migration, proliferation and apoptosis in human and rat glioblastoma cells (2020)
Miyake, Juliano Andreoli ; Gomes, Renata Nascimento ; Colquhoun, Alison
Fonte: Prostaglandins & Other Lipid Mediators. Unidade: ICB
Assuntos: BIOLOGIA CELULAR, PROSTAGLANDINAS, APOPTOSE, GLIOMA, NEOPLASIAS CEREBRAIS, ASTROCITOMA, EICOSANOIDES, CÉLULAS CULTIVADAS DE TUMOR, RATOS, PROLIFERAÇÃO CELULAR, ÁCIDOS GRAXOS, RADIOTERAPIA, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIYAKE, Juliano Andreoli e GOMES, Renata Nascimento e COLQUHOUN, Alison. Gamma-Linolenic acid alters migration, proliferation and apoptosis in human and rat glioblastoma cells. Prostaglandins & Other Lipid Mediators, v. 150, p. 4 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.prostaglandins.2020.106452. Acesso em: 19 out. 2025.
APA
Miyake, J. A., Gomes, R. N., & Colquhoun, A. (2020). Gamma-Linolenic acid alters migration, proliferation and apoptosis in human and rat glioblastoma cells. Prostaglandins & Other Lipid Mediators, 150, 4 . doi:10.1016/j.prostaglandins.2020.106452
NLM
Miyake JA, Gomes RN, Colquhoun A. Gamma-Linolenic acid alters migration, proliferation and apoptosis in human and rat glioblastoma cells [Internet]. Prostaglandins & Other Lipid Mediators. 2020 ; 150 4 .[citado 2025 out. 19 ] Available from: https://doi.org/10.1016/j.prostaglandins.2020.106452
Vancouver
Miyake JA, Gomes RN, Colquhoun A. Gamma-Linolenic acid alters migration, proliferation and apoptosis in human and rat glioblastoma cells [Internet]. Prostaglandins & Other Lipid Mediators. 2020 ; 150 4 .[citado 2025 out. 19 ] Available from: https://doi.org/10.1016/j.prostaglandins.2020.106452
Artigo de periodico
Influence of lipoxygenase inhibition on glioblastoma cell biology (2020)
Souza, Felipe da Costa ; Ferreira, Matthew Thomas ; Colquhoun, Alison
Fonte: International Journal of Molecular Sciences. Unidade: ICB
Assuntos: BIOLOGIA CELULAR, GLIOMA, ASTROCITOMA, LIPOXIGENASE, ENZIMAS OXIRREDUTORAS, ÁCIDOS GRAXOS, METABÓLITOS, ÁCIDOS ARAQUIDÔNICOS, CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA, ESPECTROMETRIA DE MASSAS, CITOMETRIA DE FLUXO, LINHAGEM CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Felipe da Costa e FERREIRA, Matthew Thomas e COLQUHOUN, Alison. Influence of lipoxygenase inhibition on glioblastoma cell biology. International Journal of Molecular Sciences, v. 21, n. 21, p. 25 , 2020Tradução . . Disponível em: https://doi.org/10.3390/ijms21218395. Acesso em: 19 out. 2025.
APA
Souza, F. da C., Ferreira, M. T., & Colquhoun, A. (2020). Influence of lipoxygenase inhibition on glioblastoma cell biology. International Journal of Molecular Sciences, 21( 21), 25 . doi:10.3390/ijms21218395
NLM
Souza F da C, Ferreira MT, Colquhoun A. Influence of lipoxygenase inhibition on glioblastoma cell biology [Internet]. International Journal of Molecular Sciences. 2020 ; 21( 21): 25 .[citado 2025 out. 19 ] Available from: https://doi.org/10.3390/ijms21218395
Vancouver
Souza F da C, Ferreira MT, Colquhoun A. Influence of lipoxygenase inhibition on glioblastoma cell biology [Internet]. International Journal of Molecular Sciences. 2020 ; 21( 21): 25 .[citado 2025 out. 19 ] Available from: https://doi.org/10.3390/ijms21218395
Artigo de periodico
Intracellular peptides in cell biology and pharmacology (2019)
Araujo, Christiane Bezerra de; Heimann, Andrea Sterman ; Remer, Ricardo A. ; Russo, Lilian Cristina ; Colquhoun, Alison ; Forti, Fabio Luis ; Ferro, Emer Suavinho
Fonte: Biomolecules. Unidades: ICB, IQ
Assuntos: BIOLOGIA CELULAR, FARMACOLOGIA, PEPTÍDEOS, EPILEPSIA, NEOPLASIAS, OBESIDADE, RESISTÊNCIA À INSULINA, CANABINOIDES, PROTEÍNAS G
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Christiane Bezerra de et al. Intracellular peptides in cell biology and pharmacology. Biomolecules, v. 9, n. 4, p. 1-28, 2019Tradução . . Disponível em: https://doi.org/10.3390/biom9040150. Acesso em: 19 out. 2025.
APA
Araujo, C. B. de, Heimann, A. S., Remer, R. A., Russo, L. C., Colquhoun, A., Forti, F. L., & Ferro, E. S. (2019). Intracellular peptides in cell biology and pharmacology. Biomolecules, 9( 4), 1-28. doi:10.3390/biom9040150
NLM
Araujo CB de, Heimann AS, Remer RA, Russo LC, Colquhoun A, Forti FL, Ferro ES. Intracellular peptides in cell biology and pharmacology [Internet]. Biomolecules. 2019 ; 9( 4): 1-28.[citado 2025 out. 19 ] Available from: https://doi.org/10.3390/biom9040150
Vancouver
Araujo CB de, Heimann AS, Remer RA, Russo LC, Colquhoun A, Forti FL, Ferro ES. Intracellular peptides in cell biology and pharmacology [Internet]. Biomolecules. 2019 ; 9( 4): 1-28.[citado 2025 out. 19 ] Available from: https://doi.org/10.3390/biom9040150
Artigo de periodico
The prostanoid pathway contains potential prognostic markers for glioblastoma (2018)
Panagopoulos, Alexandros Theodoros; Gomes, Renata Nascimento ; Almeida, Fernando Gonçalves; Souza, Felipe da Costa ; Veiga, José Carlos Esteves ; Nicolaou, Anna ; Colquhoun, Alison
Fonte: Prostaglandins & Other Lipid Mediators. Unidade: ICB
Assuntos: GLIOMA, PROSTAGLANDINAS, REAÇÃO EM CADEIA POR POLIMERASE, CROMATOGRAFIA, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PANAGOPOULOS, Alexandros Theodoros et al. The prostanoid pathway contains potential prognostic markers for glioblastoma. Prostaglandins & Other Lipid Mediators, v. 137, p. 52-62, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.prostaglandins.2018.06.003. Acesso em: 19 out. 2025.
APA
Panagopoulos, A. T., Gomes, R. N., Almeida, F. G., Souza, F. da C., Veiga, J. C. E., Nicolaou, A., & Colquhoun, A. (2018). The prostanoid pathway contains potential prognostic markers for glioblastoma. Prostaglandins & Other Lipid Mediators, 137, 52-62. doi:10.1016/j.prostaglandins.2018.06.003
NLM
Panagopoulos AT, Gomes RN, Almeida FG, Souza F da C, Veiga JCE, Nicolaou A, Colquhoun A. The prostanoid pathway contains potential prognostic markers for glioblastoma [Internet]. Prostaglandins & Other Lipid Mediators. 2018 ; 137 52-62.[citado 2025 out. 19 ] Available from: https://doi.org/10.1016/j.prostaglandins.2018.06.003
Vancouver
Panagopoulos AT, Gomes RN, Almeida FG, Souza F da C, Veiga JCE, Nicolaou A, Colquhoun A. The prostanoid pathway contains potential prognostic markers for glioblastoma [Internet]. Prostaglandins & Other Lipid Mediators. 2018 ; 137 52-62.[citado 2025 out. 19 ] Available from: https://doi.org/10.1016/j.prostaglandins.2018.06.003
Artigo de periodico
Opposing roles of PGD2 in GBM (2018)
Ferreira, Matthew Thomas ; Gomes, Renata Nascimento ; Panagopoulos, Alexandros Theodoros; Almeida, Fernando Gonçalves de; Veiga, José Carlos Esteves ; Colquhoun, Alison
Fonte: Prostaglandins & Other Lipid Mediators. Unidade: ICB
Assuntos: ONCOLOGIA, CÉREBRO, PROSTAGLANDINAS, NEOPLASIAS CEREBRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Matthew Thomas et al. Opposing roles of PGD2 in GBM. Prostaglandins & Other Lipid Mediators, v. 134, p. 66-76, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.prostaglandins.2017.10.002. Acesso em: 19 out. 2025.
APA
Ferreira, M. T., Gomes, R. N., Panagopoulos, A. T., Almeida, F. G. de, Veiga, J. C. E., & Colquhoun, A. (2018). Opposing roles of PGD2 in GBM. Prostaglandins & Other Lipid Mediators, 134, 66-76. doi:10.1016/j.prostaglandins.2017.10.002
NLM
Ferreira MT, Gomes RN, Panagopoulos AT, Almeida FG de, Veiga JCE, Colquhoun A. Opposing roles of PGD2 in GBM [Internet]. Prostaglandins & Other Lipid Mediators. 2018 ; 134 66-76.[citado 2025 out. 19 ] Available from: https://doi.org/10.1016/j.prostaglandins.2017.10.002
Vancouver
Ferreira MT, Gomes RN, Panagopoulos AT, Almeida FG de, Veiga JCE, Colquhoun A. Opposing roles of PGD2 in GBM [Internet]. Prostaglandins & Other Lipid Mediators. 2018 ; 134 66-76.[citado 2025 out. 19 ] Available from: https://doi.org/10.1016/j.prostaglandins.2017.10.002
Artigo de periodico
Eicosanoid and cancer (2018)
Gomes, Renata Nascimento ; Souza, Felipe da Costa ; Colquhoun, Alison
Fonte: Clinics. Unidade: ICB
Assuntos: EICOSANOIDES, NEOPLASIAS, PROSTAGLANDINAS, INFLAMAÇÃO, LIPOXIGENASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Renata Nascimento e SOUZA, Felipe da Costa e COLQUHOUN, Alison. Eicosanoid and cancer. Clinics, v. 73, p. 1-10, 2018Tradução . . Disponível em: https://doi.org/10.6061/clinics/2018/e530s. Acesso em: 19 out. 2025.
APA
Gomes, R. N., Souza, F. da C., & Colquhoun, A. (2018). Eicosanoid and cancer. Clinics, 73, 1-10. doi:10.6061/clinics/2018/e530s
NLM
Gomes RN, Souza F da C, Colquhoun A. Eicosanoid and cancer [Internet]. Clinics. 2018 ; 73 1-10.[citado 2025 out. 19 ] Available from: https://doi.org/10.6061/clinics/2018/e530s
Vancouver
Gomes RN, Souza F da C, Colquhoun A. Eicosanoid and cancer [Internet]. Clinics. 2018 ; 73 1-10.[citado 2025 out. 19 ] Available from: https://doi.org/10.6061/clinics/2018/e530s
Artigo de periodico
: Cell biology-metabolic crosstalk in glioma (2017)
Colquhoun, Alison
Fonte: International Journal of Biochemistry & Cell Biology. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COLQUHOUN, Alison. : Cell biology-metabolic crosstalk in glioma. International Journal of Biochemistry & Cell Biology, v. 89, p. 171-181, 2017Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0085026. Acesso em: 19 out. 2025.
APA
Colquhoun, A. (2017). : Cell biology-metabolic crosstalk in glioma. International Journal of Biochemistry & Cell Biology, 89, 171-181. doi:10.1371/journal.pone.0085026
NLM
Colquhoun A. : Cell biology-metabolic crosstalk in glioma [Internet]. International Journal of Biochemistry & Cell Biology. 2017 ; 89 171-181.[citado 2025 out. 19 ] Available from: https://doi.org/10.1371/journal.pone.0085026
Vancouver
Colquhoun A. : Cell biology-metabolic crosstalk in glioma [Internet]. International Journal of Biochemistry & Cell Biology. 2017 ; 89 171-181.[citado 2025 out. 19 ] Available from: https://doi.org/10.1371/journal.pone.0085026
Artigo de periodico
4-Nerolidylcatechol induces autophagy in human glioblastoma cells (2017)
Massaro, Renato Ramos; Brohem, Carla Abdo; Almeida, Rebeca Leite de; Rivelli, Diogo Pineda; Miyake, Juliano Andreoli; Colquhoun, Alison ; Barros, Silvia Berlanga de Moraes ; Maria-Engler, Silvya Stuchi
Fonte: Brazilian Journal of Pharmaceutical Sciences. Unidades: ICB, FCF
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASSARO, Renato Ramos et al. 4-Nerolidylcatechol induces autophagy in human glioblastoma cells. Brazilian Journal of Pharmaceutical Sciences, v. 53, n. 3, p. 1-10, 2017Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902017000300169. Acesso em: 19 out. 2025.
APA
Massaro, R. R., Brohem, C. A., Almeida, R. L. de, Rivelli, D. P., Miyake, J. A., Colquhoun, A., et al. (2017). 4-Nerolidylcatechol induces autophagy in human glioblastoma cells. Brazilian Journal of Pharmaceutical Sciences, 53( 3), 1-10. doi:10.1590/s2175-97902017000300169
NLM
Massaro RR, Brohem CA, Almeida RL de, Rivelli DP, Miyake JA, Colquhoun A, Barros SB de M, Maria-Engler SS. 4-Nerolidylcatechol induces autophagy in human glioblastoma cells [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53( 3): 1-10.[citado 2025 out. 19 ] Available from: https://doi.org/10.1590/s2175-97902017000300169
Vancouver
Massaro RR, Brohem CA, Almeida RL de, Rivelli DP, Miyake JA, Colquhoun A, Barros SB de M, Maria-Engler SS. 4-Nerolidylcatechol induces autophagy in human glioblastoma cells [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53( 3): 1-10.[citado 2025 out. 19 ] Available from: https://doi.org/10.1590/s2175-97902017000300169
Trabalho de evento-resumo
Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line (2016)
Sanches, Rute Nazaré Fernandes; Freitas, Tatiana E; Colquhoun, Alison ; Silva, Denise de Oliveira
Fonte: Resumos. Nome do evento: Brazilian Meeting on Inorganic Chemistry-BMIC. Unidades: ICB, IQ
Assuntos: GLIOMA, RUTÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANCHES, Rute Nazaré Fernandes et al. Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line. 2016, Anais.. São Paulo: Sociedade Brasileira de Química-SBQ, 2016. Disponível em: http://bmic2016.iqm.unicamp.br. Acesso em: 19 out. 2025.
APA
Sanches, R. N. F., Freitas, T. E., Colquhoun, A., & Silva, D. de O. (2016). Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line. In Resumos. São Paulo: Sociedade Brasileira de Química-SBQ. Recuperado de http://bmic2016.iqm.unicamp.br
NLM
Sanches RNF, Freitas TE, Colquhoun A, Silva D de O. Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line [Internet]. Resumos. 2016 ;[citado 2025 out. 19 ] Available from: http://bmic2016.iqm.unicamp.br
Vancouver
Sanches RNF, Freitas TE, Colquhoun A, Silva D de O. Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line [Internet]. Resumos. 2016 ;[citado 2025 out. 19 ] Available from: http://bmic2016.iqm.unicamp.br
Trabalho de evento-resumo
Could altered fatty acid and eicosanoid metabolism provide novel therapeutic targets in brain tumours? (2016)
Panagopoulos, A. T; Gomes, R. N.; Almeida, F. G. ; Souza, F. C. ; Veiga, J. C. E.; Colquhoun, Alison
Fonte: Resumos. Nome do evento: Prof. Eric A. Newsholme Research Symposium Metabolic Regulation. Unidade: ICB
Assunto: BIOLOGIA CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PANAGOPOULOS, A. T et al. Could altered fatty acid and eicosanoid metabolism provide novel therapeutic targets in brain tumours? 2016, Anais.. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo, 2016. . Acesso em: 19 out. 2025.
APA
Panagopoulos, A. T., Gomes, R. N., Almeida, F. G., Souza, F. C., Veiga, J. C. E., & Colquhoun, A. (2016). Could altered fatty acid and eicosanoid metabolism provide novel therapeutic targets in brain tumours? In Resumos. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Panagopoulos AT, Gomes RN, Almeida FG, Souza FC, Veiga JCE, Colquhoun A. Could altered fatty acid and eicosanoid metabolism provide novel therapeutic targets in brain tumours? Resumos. 2016 ;[citado 2025 out. 19 ]
Vancouver
Panagopoulos AT, Gomes RN, Almeida FG, Souza FC, Veiga JCE, Colquhoun A. Could altered fatty acid and eicosanoid metabolism provide novel therapeutic targets in brain tumours? Resumos. 2016 ;[citado 2025 out. 19 ]

Unidades USP

ReP

Filtros

Tipo de material

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos